BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2785352)

  • 1. 131I-metaiodobenzylguanidine in the treatment of neuroblastoma at diagnosis.
    Mastrangelo R; Troncone L; Lasorella A; Riccardi R; Montemaggi P; Rufini V
    Am J Pediatr Hematol Oncol; 1989; 11(1):28-31. PubMed ID: 2785352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [131I]metaiodobenzylguanidine in neuroblastoma patients at diagnosis.
    Mastrangelo R; Lasorella A; Troncone L; Rufini V; Iavarone A; Riccardi R
    J Nucl Biol Med (1991); 1991; 35(4):252-4. PubMed ID: 1823829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with meta-[131I]iodobenzylguanidine and cisplatin in stage IV neuroblastoma.
    Mastrangelo S; Tornesello A; Diociaiuti L; Riccardi R; Rufini V; Troncone L
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):69-71. PubMed ID: 9002754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical observations on neuroblastoma treatment with 131-I-metaiodobenzylguanidine at diagnosis.
    Mastrangelo R; Lasorella A; Iavarone A; Rufini V; Troncone L; Danza F; Riccardi R
    Med Pediatr Oncol; 1993; 21(6):411-5. PubMed ID: 8515721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of neuroblastoma with 131I-metaiodobenzylguanidine.
    Troncone L; Riccardi R; Montemaggi P; Rufini V; Lasorella A; Mastrangelo R
    Med Pediatr Oncol; 1987; 15(4):220-3. PubMed ID: 3657712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new approach in the treatment of stage IV neuroblastoma using a combination of [131I]meta-iodobenzylguanidine (MIBG) and cisplatin.
    Mastrangelo R; Tornesello A; Riccardi R; Lasorella A; Mastrangelo S; Mancini A; Rufini V; Troncone L
    Eur J Cancer; 1995; 31A(4):606-11. PubMed ID: 7576979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative [131I]metaiodobenzylguanidine therapy of neuroblastoma at diagnosis ("MIBG de novo").
    Hoefnagel CA; de Kraker J; Voûte PA; Valdés Olmos RA
    J Nucl Biol Med (1991); 1991; 35(4):248-51. PubMed ID: 1823828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Considerations on 131I-metaiodobenzylguanidine therapy of six children with neuroblastoma.
    Sanguineti M
    Med Pediatr Oncol; 1987; 15(4):212-5. PubMed ID: 3657710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The treatment of neuroblastoma with [131I]MIBG at diagnosis.
    Troncone L; Rufini V; Luzi S; Mastrangelo R; Riccardi R
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):65-8. PubMed ID: 9002753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 131I-MIBG as a first-line treatment in high-risk neuroblastoma patients.
    Hoefnagel CA; De Kraker J; Valdés Olmos RA; Voûte PA
    Nucl Med Commun; 1994 Sep; 15(9):712-7. PubMed ID: 7816384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretreatment with [131I] metaiodobenzylguanidine and surgical resection of advanced neuroblastoma.
    van Hasselt EJ; Heij HA; de Kraker J; Vos A; Voûte PA
    Eur J Pediatr Surg; 1996 Jun; 6(3):155-8. PubMed ID: 8817208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of neuroblastoma with 131I-metaiodobenzylguanidine: experience of the Münster/Kassel Group.
    Fischer M; Wehinger H; Kraus C; Ritter J; Schröter W
    Med Pediatr Oncol; 1987; 15(4):196-8. PubMed ID: 3657707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosimetry of iodine 131 metaiodobenzylguanidine for treatment of resistant neuroblastoma: results of a UK study.
    Fielding SL; Flower MA; Ackery D; Kemshead JT; Lashford LS; Lewis I
    Eur J Nucl Med; 1991; 18(5):308-16. PubMed ID: 1936038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [131I]MIBG as a first line treatment in advanced neuroblastoma.
    Hoefnagel CA; De Kraker J; Valdés Olmos RA; Voûte PA
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):61-4. PubMed ID: 9002752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of neuroblastoma with [131I]metaiodobenzylguanidine: long-term results in 25 patients.
    Klingebiel T; Feine U; Treuner J; Reuland P; Handgretinger R; Niethammer D
    J Nucl Biol Med (1991); 1991; 35(4):216-9. PubMed ID: 1823821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical experiences in the treatment of neuroblastoma with 131I-metaiodobenzylguanidine.
    Treuner J; Klingebiel T; Feine U; Buck J; Bruchelt G; Dopfer R; Girgert R; Müller-Schauenburg W; Meinke J; Kaiser W
    Pediatr Hematol Oncol; 1986; 3(3):205-16. PubMed ID: 2484676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment planning for 131I-mIBG radiotherapy of neural crest tumours using 124I-mIBG positron emission tomography.
    Ott RJ; Tait D; Flower MA; Babich JW; Lambrecht RM
    Br J Radiol; 1992 Sep; 65(777):787-91. PubMed ID: 1393416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Place of meta-[131I]iodobenzylguanidine in the treatment of neuroblastoma: the Genoa experience.
    Garaventa A; Pianca C; Conte M; Nigro M; De Bernardi B; Claudiani F; Stimamiglio P; Bertolazzi L; Cabria M; Villavecchia GP
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):58-60. PubMed ID: 9002751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 131I-meta-iodobenzylguanidine therapy in neuroblastoma spheroids of different sizes.
    Gaze MN; Mairs RJ; Boyack SM; Wheldon TE; Barrett A
    Br J Cancer; 1992 Dec; 66(6):1048-52. PubMed ID: 1457344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [131I]metaiodobenzylguanidine therapy in advanced neuroblastoma.
    Claudiani F; Garaventa A; Bertolazzi L; Villavecchia GP; Cabria M; Scopinaro G; Bestagno M; Guerra P; Canevarollo N; Scielzo G
    J Nucl Biol Med (1991); 1991; 35(4):224-7. PubMed ID: 1823823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.